These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21959273)

  • 21. Biosafety of viral vectors commonly used in gene therapy and vaccination.
    Herman P
    Curr Gene Ther; 2013 Dec; 13(6):383-4. PubMed ID: 24397526
    [No Abstract]   [Full Text] [Related]  

  • 22. New hopes for gene therapy.
    Gross M
    Curr Biol; 2014 Oct; 24(20):R983-6. PubMed ID: 25587582
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetics and Gene Therapy in Hunter Disease.
    Sestito S; Falvo F; Scozzafava C; Apa R; Pensabene L; Bonapace G; Moricca MT; Concolino D
    Curr Gene Ther; 2018; 18(2):90-95. PubMed ID: 29618310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy and molecular toxicology: a commentary.
    Robbins J
    Cardiovasc Toxicol; 2001; 1(1):3-5. PubMed ID: 12213992
    [No Abstract]   [Full Text] [Related]  

  • 25. A look to future directions in gene therapy research for monogenic diseases.
    Porteus MH; Connelly JP; Pruett SM
    PLoS Genet; 2006 Sep; 2(9):e133. PubMed ID: 17009872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination.
    Baldo A; van den Akker E; Bergmans HE; Lim F; Pauwels K
    Curr Gene Ther; 2013 Dec; 13(6):385-94. PubMed ID: 24195604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosafety considerations using gamma-retroviral vectors in gene therapy.
    Deichmann A; Schmidt M
    Curr Gene Ther; 2013 Dec; 13(6):469-77. PubMed ID: 24195605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rapidly evolving state of gene therapy.
    Gruntman AM; Flotte TR
    FASEB J; 2018 Apr; 32(4):1733-1740. PubMed ID: 31282760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ophthalmogenetics: Rare Diseases - A Challenge for Diagnostic and Treatment].
    Rudolph G
    Klin Monbl Augenheilkd; 2016 Mar; 232(3):242. PubMed ID: 27011027
    [No Abstract]   [Full Text] [Related]  

  • 30. Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.
    Gruntman AM; Flotte TR
    Hum Gene Ther Methods; 2015 Jun; 26(3):77-81. PubMed ID: 26067712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene therapy, where does it stand today].
    Hacein-Bey-Abina S
    J Med Liban; 2004; 52(1):32. PubMed ID: 15881699
    [No Abstract]   [Full Text] [Related]  

  • 32. Biosafety challenges for use of lentiviral vectors in gene therapy.
    Rothe M; Modlich U; Schambach A
    Curr Gene Ther; 2013 Dec; 13(6):453-68. PubMed ID: 24195603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics and Gene Therapy of Anderson-Fabry Disease.
    Simonetta I; Tuttolomondo A; Di Chiara T; Miceli S; Vogiatzis D; Corpora F; Pinto A
    Curr Gene Ther; 2018; 18(2):96-106. PubMed ID: 29618309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gendicine: the first commercial gene therapy product.
    Wilson JM
    Hum Gene Ther; 2005 Sep; 16(9):1014-5. PubMed ID: 16149899
    [No Abstract]   [Full Text] [Related]  

  • 35. Gene therapy revisited. In spite of problems and drawbacks, gene therapy moves forward.
    Brower V
    EMBO Rep; 2001 Dec; 2(12):1064-5. PubMed ID: 11743014
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapy: hopes, hypes, and hurdles.
    Verma IM
    Mol Med; 1994 Nov; 1(1):2-3. PubMed ID: 8790596
    [No Abstract]   [Full Text] [Related]  

  • 37. Hidradenitis Suppurativa: New Opportunities for an Orphan Skin Disease.
    Carrascosa JM; Bassas J; Puig L
    Actas Dermosifiliogr; 2015; 106(6):448-51. PubMed ID: 25796270
    [No Abstract]   [Full Text] [Related]  

  • 38. Would gene therapy for the treatment of male infertility be safe?
    Lamb DJ
    Nat Clin Pract Urol; 2008 Nov; 5(11):594-5. PubMed ID: 18852705
    [No Abstract]   [Full Text] [Related]  

  • 39. Cardiac gene therapy: are we there yet?
    Matkar PN; Leong-Poi H; Singh KK
    Gene Ther; 2016 Aug; 23(8-9):635-48. PubMed ID: 27128687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-Mediated Immunity to NAGLU Transgene Following Intracerebral Gene Therapy in Children With Mucopolysaccharidosis Type IIIB Syndrome.
    Gougeon ML; Poirier-Beaudouin B; Ausseil J; Zérah M; Artaud C; Heard JM; Deiva K; Tardieu M
    Front Immunol; 2021; 12():655478. PubMed ID: 34040605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.